Research Article
Predicting Low-Risk Prostate Cancer from Transperineal Saturation Biopsies
Table 2
Patients characteristics.
| | Variable | All | Criterion 1 | Criterion 2 | Criterion 3 | Criterion 4 | Criterion 5 |
| | Number of patients | 994 | 52 | 78 | 127 | 219 | 319 | | Median (IQR) | | | | | | | | Age | 62 | 60 (57–63) | 60 (56–64) | 60 (55–64) | 59 (55–63) | 60 (55–64) | | PSA ng/mL | 5.5 | 5.5 (4.0–7.2) | 5.5 (4.2–6.8) | 5.5 (4.1–7.0) | 5.1 (3.8–6.3) | 5.1 (3.8–6.3) | | Prostate volume | 49.0 | 53.0 (45–69) | 53.0 (44–70) | 52.0 (44–62) | 49.0 (41–57) | 48.0 (40–56) | | Number of cores | 27 | 28 | 28 | 28 | 28 | 28 | | % positive cores | 25.0 | 9.5 | 11.1 | 12.5 | 18.8 | 21.4 | | Clinical stage, (%) | | | | | | | | T1c | 537 (54.0) | 43 (82.7) | 62 (79.5) | 93 (73.2) | 151 (68.9) | 208 (65.2) | | T2a | 312 (31.4) | 5 (9.6) | 11 (14.1) | 22 (17.3) | 47 (21.5) | 73 (22.9) | | T2b | 72 (7.3) | 1 (1.9) | 2 (3.8) | 3 (2.4) | 11 (5.0) | 15 (4.7) | | T2c | 73 (7.3) | 3 (5.8) | 3 (2.6) | 9 (7.1) | 10 (4.6) | 23 (7.2) | | Biopsy Gleason score, (%) | | | | | | | | 3 + 3 | 221 (22.2) | 52(100) | 78 (100) | 99 (78.0) | 219 (100) | 218 (68.3) | | 3 + 4 | 581 (58.5) | | | 28 (22.0) | | 101 (31.7) | | 4 + 3 | 192 (19.3) | | | | | |
|
|
